Hecht SS - Search Results

1

Biomarkers of exposure to new and emerging tobacco delivery products.

Schick SF, Blount BC, Jacob P Rd, Saliba NA, Bernert JT, El Hellani A, Jatlow P, Pappas RS, Wang L, Foulds J, Ghosh A, Hecht SS, Gomez JC, Martin JR, Mesaros C, Srivastava S, St Helen G, Tarran R, Lorkiewicz PK, Blair IA, Kimmel HL, Doerschuk CM, Benowitz NL, Bhatnagar A. Schick SF, et al. Among authors: hecht ss. Am J Physiol Lung Cell Mol Physiol. 2017 Sep 1;313(3):L425-L452. doi: 10.1152/ajplung.00343.2016. Epub 2017 May 18. Am J Physiol Lung Cell Mol Physiol. 2017. PMID: 28522563 Free PMC article. Review.

2

Tobacco and cancer: approaches using carcinogen biomarkers and chemoprevention.

Hecht SS. Hecht SS. Ann N Y Acad Sci. 1997 Dec 29;833:91-111. doi: 10.1111/j.1749-6632.1997.tb48596.x. Ann N Y Acad Sci. 1997. PMID: 9616743 Review.

3

Biomarkers of tobacco exposure or harm: application to clinical and epidemiological studies. 25-26 October 2001, Minneapolis, Minnesota.

Hatsukami DK, Hecht SS, Hennrikus DJ, Joseph AM, Pentel PR. Hatsukami DK, et al. Among authors: hecht ss. Nicotine Tob Res. 2003 Jun;5(3):387-96. doi: 10.1080/1462220031000094222. Nicotine Tob Res. 2003. PMID: 12791522

4

Evaluation of carcinogen exposure in people who used "reduced exposure" tobacco products.

Hatsukami DK, Lemmonds C, Zhang Y, Murphy SE, Le C, Carmella SG, Hecht SS. Hatsukami DK, et al. Among authors: hecht ss. J Natl Cancer Inst. 2004 Jun 2;96(11):844-52. doi: 10.1093/jnci/djh163. J Natl Cancer Inst. 2004. PMID: 15173268 Clinical Trial.

5

A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers.

Murphy SE, Link CA, Jensen J, Le C, Puumala SS, Hecht SS, Carmella SG, Losey L, Hatsukami DK. Murphy SE, et al. Among authors: hecht ss. Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1617-23. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15466978 Clinical Trial.

6

Biomarkers to assess the utility of potential reduced exposure tobacco products.

Hatsukami DK, Benowitz NL, Rennard SI, Oncken C, Hecht SS. Hatsukami DK, et al. Among authors: hecht ss. Nicotine Tob Res. 2006 Apr;8(2):169-91. doi: 10.1080/14622200600576628. Nicotine Tob Res. 2006. PMID: 16766411 Corrected and republished. Review.

7

Biomarkers to assess the utility of potential reduced exposure tobacco products.

Hatsukami DK, Benowitz NL, Rennard SI, Oncken C, Hecht SS. Hatsukami DK, et al. Among authors: hecht ss. Nicotine Tob Res. 2006 Aug;8(4):600-22. doi: 10.1080/14622200600858166. Nicotine Tob Res. 2006. PMID: 16920658 Free PMC article. Review.

8

Relationship of human toenail nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol to levels of these biomarkers in plasma and urine.

Stepanov I, Hecht SS, Lindgren B, Jacob P 3rd, Wilson M, Benowitz NL. Stepanov I, et al. Among authors: hecht ss. Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1382-6. doi: 10.1158/1055-9965.EPI-07-0145. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17627002 Free article.

9

Changing smokeless tobacco products new tobacco-delivery systems.

Hatsukami DK, Ebbert JO, Feuer RM, Stepanov I, Hecht SS. Hatsukami DK, et al. Among authors: hecht ss. Am J Prev Med. 2007 Dec;33(6 Suppl):S368-78. doi: 10.1016/j.amepre.2007.09.005. Am J Prev Med. 2007. PMID: 18021912 Review.

10

Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level.

Strasser AA, Benowitz NL, Pinto AG, Tang KZ, Hecht SS, Carmella SG, Tyndale RF, Lerman CE. Strasser AA, et al. Among authors: hecht ss. Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):234-8. doi: 10.1158/1055-9965.EPI-10-0674. Epub 2011 Jan 6. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21212060 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

767 results

Search Page